$270.61 +0.14 (%) Actavis PLC - NYSE

Nov. 28, 2014 | 01:01 PM

Partner Headlines

  1. Valeant Rises After Allergan Snub; Zeltiq In Buy Area

    IBD | Nov. 19, 2014 | 18:14PM EST
  2. Mallinckrodt Q4 Earnings Beat Views, But Outlook Hazy

    IBD | Nov. 19, 2014 | 17:35PM EST
  3. Mallinckrodt Earnings Beat But No New Guidance

    IBD | Nov. 19, 2014 | 11:42AM EST
  4. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  5. Nasdaq, S&P, Dow Hit Highs

    IBD | Nov. 18, 2014 | 18:50PM EST
  6. Actavis'

    IBD | Nov. 18, 2014 | 18:42PM EST
  7. Vipshop, Jack in the Box Rise In After-Hours Trading

    IBD | Nov. 18, 2014 | 17:04PM EST
  8. Dow, S&P 500 Add To Gains Following Encouraging International News

    Benzinga | Nov. 18, 2014 | 17:02PM EST
  9. Stocks Hit New Milestones; BitAuto Rebounds

    IBD | Nov. 18, 2014 | 16:17PM EST
  10. Zoetis 2015 Guidance Misses As Buyout Theories Abound

    IBD | Nov. 18, 2014 | 15:15PM EST
  11. Stock Movers: Why 4 Big Drug Stocks Are Rising Today

    IBD | Nov. 18, 2014 | 14:38PM EST
  12. Bill Ackman Says He Supports The Allergan-Actavis Deal And CEO Brent Saunders

    Benzinga | Nov. 18, 2014 | 14:17PM EST
  13. Stocks Hold Near Fresh Milestones; Actavis Hits New High

    IBD | Nov. 18, 2014 | 13:33PM EST
  14. Ackman Pledges Support For Actavis Bid On Allergan

    Benzinga | Nov. 18, 2014 | 13:10PM EST
  15. Is Bill Ackman Back?

    Benzinga | Nov. 18, 2014 | 10:56AM EST
  16. Benzinga's Volume Movers

    Benzinga | Nov. 18, 2014 | 10:36AM EST
  17. Citi Raises Price Target On Actavis

    Benzinga | Nov. 18, 2014 | 08:44AM EST
  18. #PreMarket Primer: Tuesday, November 18: Abe To Delay Sales Tax Increase In Japan

    Benzinga | Nov. 18, 2014 | 07:23AM EST
  19. Here Are Some Big Caps Poised To Make Gains

    IBD | Nov. 17, 2014 | 18:45PM EST
  20. Allergan Takes A Better Offer

    IBD | Nov. 17, 2014 | 18:39PM EST
  21. Five Ethical Drugmakers Keep Leadership Positions

    IBD | Nov. 17, 2014 | 18:27PM EST
  22. Benzinga's M&A Chatter for Monday November 17, 2014

    Benzinga | Nov. 17, 2014 | 18:11PM EST
  23. Actavis' $66 Bil Offer Steals Allergan From Valeant

    IBD | Nov. 17, 2014 | 17:31PM EST
  24. U.S. Markets Recover From Early-Day Losses As Japan's Economy Contracts

    Benzinga | Nov. 17, 2014 | 16:46PM EST
  25. Stocks End Mixed As Allergan Jumps On Actavis Deal

    IBD | Nov. 17, 2014 | 16:16PM EST
  26. Stocks Mixed In Afternoon; Allergan Jumps To New High

    IBD | Nov. 17, 2014 | 15:13PM EST
  27. Mid-Day Market Update: Allergan Jumps On Actavis Bid; Denbury Resources Shares Slip

    Benzinga | Nov. 17, 2014 | 13:23PM EST
  28. Top Performing Industries For November 17, 2014

    Benzinga | Nov. 17, 2014 | 10:46AM EST
  29. Mid-Morning Market Update: Markets Edge Lower; Halliburton To Acquire Baker Hughes For $34.6 Billion

    Benzinga | Nov. 17, 2014 | 10:42AM EST
  30. Benzinga's Volume Movers

    Benzinga | Nov. 17, 2014 | 10:29AM EST
  31. Stocks Hitting 52-Week Highs

    Benzinga | Nov. 17, 2014 | 10:18AM EST
  32. Actavis Nabs Allergan For $66 Billion; Valeant Folds

    IBD | Nov. 17, 2014 | 10:17AM EST
  33. Actavis plc Buying Allergan In $66 Billion Deal

    Benzinga | Nov. 17, 2014 | 10:06AM EST
  34. Morning Market Movers

    Benzinga | Nov. 17, 2014 | 09:51AM EST
  35. Actavis to Acquire Allergan To Create Top 10 Global Growth Pharmaceutical Company with $23B In Revenue

    Benzinga | Nov. 17, 2014 | 09:17AM EST
  36. Stock Futures Set For Weak Open; Halliburton, Baker Hughes Merge

    IBD | Nov. 17, 2014 | 09:12AM EST
  37. #PreMarket Primer: Monday, November 17: Japan's Economy Unexpectedly Slips

    Benzinga | Nov. 17, 2014 | 08:33AM EST
  38. Must Watch Stocks for Today

    Benzinga | Nov. 17, 2014 | 04:59AM EST
  39. Benzinga's Weekend M&A Chatter

    Benzinga | Nov. 16, 2014 | 20:30PM EST
  40. Actavis, Allergan Could Announce Merger Deal Monday

    Benzinga | Nov. 16, 2014 | 15:08PM EST
  41. Eye Best Mutual Funds Like Magellan For Great Stocks

    IBD | Nov. 14, 2014 | 17:50PM EST
  42. Report: Pfizer 'Unlikely' To Pursue Acquisition Of AstraZeneca

    Benzinga | Nov. 14, 2014 | 09:38AM EST
  43. Mallinckrodt ADHD Drug Hits FDA Trouble; Stock Drops

    IBD | Nov. 13, 2014 | 11:09AM EST
  44. Allergan buyout said nearing

    IBD | Nov. 12, 2014 | 18:51PM EST
  45. All Quiet On The Market Front: Dow, S&P 500, Nasdaq Virtually Flat

    Benzinga | Nov. 12, 2014 | 16:38PM EST
  46. Actavis, Allergan Reported Near Deal As Valeant Lurks

    IBD | Nov. 12, 2014 | 12:43PM EST
  47. Allergan Spikes Higher On Acquisition Report

    Benzinga | Nov. 12, 2014 | 10:45AM EST
  48. Use Daily, Weekly Charts To See Institutional Buying

    IBD | Nov. 11, 2014 | 17:23PM EST
  49. A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio

    GuruFocus | Nov. 9, 2014 | 18:16PM EST
  50. Stocks On Indefinite Tack; Rumors See Actavis Merger

    IBD | Nov. 6, 2014 | 12:05PM EST
Trading Center